🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BioCorRx Inc. (BICX)
OTCMKTS · Delayed Price · Currency is USD
0.2255
+0.016187 (7.73%)
At close: Nov 17, 2026

BioCorRx Statistics

Total Valuation

BioCorRx has a market cap or net worth of 6.79 million. The enterprise value is 8.83 million.

Market Cap6.79M
Enterprise Value 8.83M

Important Dates

The next estimated earnings date is Friday, November 20, 2026.

Earnings Date Nov 20, 2026
Ex-Dividend Date n/a

Share Statistics

BioCorRx has 30.09 million shares outstanding. The number of shares has increased by 70.62% in one year.

Current Share Class 30.09M
Shares Outstanding 30.09M
Shares Change (YoY) +70.62%
Shares Change (QoQ) +3.01%
Owned by Insiders (%) 51.84%
Owned by Institutions (%) n/a
Float 12.27M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 17.10
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 22.24
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.06

Current Ratio 0.06
Quick Ratio 0.01
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -6.68

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -62.72%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 63.34%
Weighted Average Cost of Capital (WACC) 9.54%
Revenue Per Employee 132,296
Profits Per Employee -1.08M
Employee Count 3
Asset Turnover 0.09
Inventory Turnover 1.22

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -49.67% in the last 52 weeks. The beta is 0.07, so BioCorRx's price volatility has been lower than the market average.

Beta (5Y) 0.07
52-Week Price Change -49.67%
50-Day Moving Average 0.25
200-Day Moving Average 0.33
Relative Strength Index (RSI) 49.72
Average Volume (20 Days) 1,342

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BioCorRx had revenue of 396,887 and -3.23 million in losses. Loss per share was -0.13.

Revenue396,887
Gross Profit 202,309
Operating Income -4.68M
Pretax Income -3.29M
Net Income -3.23M
EBITDA -4.77M
EBIT -4.68M
Loss Per Share -0.13
Full Income Statement

Balance Sheet

The company has 18,233 in cash and 2.30 million in debt, with a net cash position of -2.28 million or -0.08 per share.

Cash & Cash Equivalents 18,233
Total Debt 2.30M
Net Cash -2.28M
Net Cash Per Share -0.08
Equity (Book Value) -13.02M
Book Value Per Share -0.42
Working Capital -8.65M
Full Balance Sheet

Cash Flow

Operating Cash Flow -1.95M
Capital Expenditures n/a
Depreciation & Amortization -95,301
Net Borrowing -182,218
Free Cash Flow -1.95M
FCF Per Share -0.06
Full Cash Flow Statement

Margins

Gross Margin 50.97%
Operating Margin -1,179.07%
Pretax Margin -829.42%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BioCorRx does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -70.62%
Shareholder Yield -70.62%
Earnings Yield -55.72%
FCF Yield -28.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on January 22, 2019. It was a reverse split with a ratio of 0.01.

Last Split Date Jan 22, 2019
Split Type Reverse
Split Ratio 0.01

Scores

Altman Z-Score n/a
Piotroski F-Score 2